Drug Topics

NOVEMBER 10, 2022

Medication only works when it's taken, which makes adherence necessary. The approach can't be "one size fits all".

548

548

PharmaVoice

NOVEMBER 10, 2022

Behind the pharma giant’s plans to build the first quantum computer by 2034 to accelerate drug development.

264

264

Drug Topics

NOVEMBER 10, 2022

For pharmacy owners, understanding tax code can lead to financial benefits at tax time.

502

502

PhRMA

NOVEMBER 10, 2022

The Working for Cures Employee Champion Awards celebrate the real people in our industry who go above and beyond to advance science and support the work our industry does for patients.

262

262

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

NOVEMBER 10, 2022

An over-the-counter (OTC) progestin only pill (POP) could potentially reduce the overall number of unintended pregnancies in the United States.

465

465

PhRMA

NOVEMBER 10, 2022

Have you ever noticed that one medicine might be used to treat two, three, seven different conditions? That’s the result of significant additional research and investment, including lengthy and costly clinical trials, biopharmaceutical companies undertake after a medicine is initially approved by the Food and Drug Administration (FDA). Such post approval R&D has changed the course of treatment for many diseases and patient populations.

FDA 254

FDA 254

PharmaVoice

NOVEMBER 10, 2022

If “winter is coming” in the form of a recession, pharmas can take advantage of an inherent resiliency by crushing these three fundamentals.

246

246

Drug Topics

NOVEMBER 10, 2022

Drs Goldman and Meece explore an array of drug therapies available to treat diabetes.

247

247

Fierce Pharma

NOVEMBER 10, 2022

AstraZeneca withdraws US COVID vaccine application, shifts focus to antibody treatments. aliu. Thu, 11/10/2022 - 09:02.

Vaccines 145

Vaccines 145

Drug Topics

NOVEMBER 10, 2022

Drs Goldman and Meece discuss factors surrounding insulin administration.

247

247

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

NOVEMBER 10, 2022

SAN DIEGO — Rayyan Gorashi is keeping her options open. After all, she’s still a second-year bioengineering Ph.D. student at UC San Diego, and there are so many careers to explore. Patent law has been high up on her list ever since a class she took in college. There’s also regulatory affairs. Oh, and science publishing sounds interesting, too.

140

140

Drug Topics

NOVEMBER 10, 2022

Dr Meece navigates insulin therapy education and ensuring patient adherence.

247

247

Pharmacy Times

NOVEMBER 10, 2022

Study shows there are 2.5 times more breast cancer survivors since the last estimate was conducted in 2007.

139

139

Fierce Healthcare

NOVEMBER 10, 2022

CMS looking at quality metrics to get ACA exchange plans into value-based care. rking. Thu, 11/10/2022 - 16:00.

127

127

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

NOVEMBER 10, 2022

Expert health professionals share their thoughts on variants of concern vs variants of interest of the SARS-CoV-2 strains as they relate to clinical practice.

139

139

STAT

NOVEMBER 10, 2022

Changing the way cancer drugs are priced in the U.S. is apparently even harder than it sounds. EQRx, a company founded to upend the costly U.S. system for pricing new drugs, said Thursday it would abandon that goal for the two products that are closest to the market.

121

121

Pharmacy Times

NOVEMBER 10, 2022

Pharmacists and health care providers should be familiar with the management of xylazine overdose and withdrawal.

132

132

STAT

NOVEMBER 10, 2022

Longtime Sage Therapeutics executive Jeff Jonas is leaving the biotech company to launch a biotech incubator with global investment giant CBC Group. Sage announced this week that Jonas would leave the company to join a private equity firm. He has been part of the C-suite at Sage Therapeutics since 2013. He helped the company go public, build a pipeline of new antidepressants and other psychiatric medications, and sign a $1.5 billion deal with Biogen.

118

118

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

NOVEMBER 10, 2022

Cerebral adrenoleukodystrophy is a progressive neurodegenerative disease causes irreversible neurologic decline and can result in functional disabilities, such hearing loss and cortical blindness.

132

132

Fierce Healthcare

NOVEMBER 10, 2022

Humana's CenterWell to open 3 clinics in Louisville next year. pminemyer. Thu, 11/10/2022 - 13:12.

115

115

Pharmacy Times

NOVEMBER 10, 2022

The book aims to make the vaccination process less scary and allow more children to be vaccinated.

Vaccines 123

Vaccines 123

European Pharmaceutical Review

NOVEMBER 10, 2022

Minoryx Therapeutics focused on the development of treatments for orphan central nervous system (CNS) disorders and the Neuraxpharm Group announced the completion of a strategic licence agreement. Under the agreement, Minoryx grants Neuraxpharm exclusive European rights to its lead candidate: leriglitazone. Neuraxpharm obtains exclusive rights to commercialise leriglitazone in Europe and will join with Minoryx to continue the further development of leriglitazone.

FDA 115

FDA 115

Pharmacy Times

NOVEMBER 10, 2022

One day soon, including pharmacogenomics testing for all patients will be essential for precise prescribing.

123

123

Fierce Pharma

NOVEMBER 10, 2022

Sanofi, GSK crash the COVID-19 vaccine party late with a world-first nod for their next-gen booster. fkansteiner. Thu, 11/10/2022 - 14:09.

Vaccines 108

Vaccines 108

Pharmacy Times

NOVEMBER 10, 2022

FDA approves brentuximab vedotin for the treatment of patients aged 2 years and older with previously untreated, high-risk classical Hodgkin lymphoma, in combination with doxorubicin, vincristine, etoposide, prednisone, and cyclophosphamide.

FDA 123

FDA 123

Fierce Healthcare

NOVEMBER 10, 2022

KFF: Seniors have, on average, 43 Medicare Advantage plan options to choose from. rking. Thu, 11/10/2022 - 16:42.

106

106

Pharmacy Times

NOVEMBER 10, 2022

FDA committee voted that trial data do not support the benefits outweighing the risks in patients aged 12 to 17 years and children aged 4 to 11 years for the use of albuterol/budesonide in the treatment of asthma.

FDA 123

FDA 123

European Pharmaceutical Review

NOVEMBER 10, 2022

A new wave of medicines has emerged in recent years to supplement the well-established small and large molecule platforms that have historically dominated the market. Complex medicines offer diverse therapeutic modalities, including RNA therapeutics and antibody-drug conjugates (ADCs). Advanced light microscopy techniques are one tool that can be used to understand these medicines.

Labelling 105

Labelling Compounding 105

Pharmacy Times

NOVEMBER 10, 2022

A physician working in the field of palliative care discusses how pharmacists and physicians can work together to help address issues pertaining to polypharmacy through deprescribing.

123

123

STAT

NOVEMBER 10, 2022

Colorado looks set to legalize magic mushrooms in this week’s midterm elections, with the group opposing the ballot question conceding defeat. As of Thursday afternoon, Proposition 122 was passing with 51.4% of the vote, though the referendum is still too close to call officially, with 89% of the vote counted. Colorado would be the second state to legalize psychedelics, following Oregon’s 2020 passage of a similar ballot question.

105

105

Pharmacy Times

NOVEMBER 10, 2022

Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, leads a discussion on the challenges subvariants of SARS-CoV-2 present in terms of vaccination and approaching optimal communication to the public surrounding vaccination.

Vaccines 122

Vaccines Communication 122

STAT

NOVEMBER 10, 2022

Read in English | Leer en inglés. H ARLINGEN, Texas — Aquí en el Valle del Río Grande casi todo el mundo conoce, o cuida, a alguien con demencia. No es ninguna sorpresa. La región presenta algunas de las tasas más altas de la enfermedad en el país. Pero lo que se aprecia menos es la enormidad de la carga que soportan los cuidadores, en su mayoría mexicano-americanos.

105

105

Fierce Healthcare

NOVEMBER 10, 2022

Bright Health further slims MA footprint as it charts course for profitability. pminemyer. Thu, 11/10/2022 - 15:45.

104

104